| abstract |
The present invention relates to vascular targeting agents for the treatment of ocular neovascularization, ocular tumors, and conditions such as diabetic retinopathy, retinopathy of prematurity, retinoblastoma and macular degeneration, in particular, It relates to the administration of tubulin binding agents. The present invention provides a method for treating an ocular disease, the method comprising the following steps: a) preparing a dosage containing a pharmaceutically effective dosage of a tubulin binding agent; b) Administering the pharmaceutically effective dosage to a subject in need of such treatment. |